Vohra Ravinder S, Walker John H, Howell Gareth J, Homer-Vanniasinkam Shervanthi, Ponnambalam Sreenivasan
Endothelial Cell Biology Unit, Institute of Molecular & Cellular Biology, Leeds Institute of Genetics, Health & Therapeutics Laboratories, University of Leeds, Leeds, UK.
Biochem Biophys Res Commun. 2009 May 29;383(2):269-74. doi: 10.1016/j.bbrc.2009.04.012. Epub 2009 Apr 7.
Oxidized low-density lipoprotein particles is a pro-atherogenic factor implicated in atherosclerotic plaque formation. The LOX-1 scavenger receptor binds OxLDL and is linked to atherosclerotic plaque initiation and progression. We tested the hypothesis that the LOX-1 cytoplasmic domain contains a transplantable signal for membrane protein endocytosis. Structural modeling of the LOX-1 cytoplasmic domain reveals that a tripeptide motif (DDL) implicated in LOX-1 endocytosis is part of a curved beta-pleated sheet structure. The two aspartic acid residues within this structural model are highly solvent-accessible enabling recognition by cytosolic factor(s). A triple alanine substitution of the DDL motif within the LOX-1 scavenger receptor substantially reduced endocytosis of OxLDL. Transplantation of the LOX-1 cytoplasmic domain into a transferrin receptor reporter molecule conferred efficient endocytosis on this hybrid protein. Mutation of the DDL motif within the hybrid LOX-1-TfR protein also substantially reduced receptor-mediated endocytosis. Thus a transplantable endocytic motif within the LOX-1 cytoplasmic domain is needed to ensure efficient internalization of pro-atherogenic OxLDL particles.
氧化型低密度脂蛋白颗粒是一种促动脉粥样硬化因子,与动脉粥样硬化斑块形成有关。凝集素样氧化低密度脂蛋白受体1(LOX-1)清道夫受体可结合氧化型低密度脂蛋白(OxLDL),并与动脉粥样硬化斑块的起始和进展相关。我们验证了以下假说:LOX-1胞质结构域包含一个可移植的膜蛋白内吞信号。LOX-1胞质结构域的结构建模显示,与LOX-1内吞作用相关的一个三肽基序(DDL)是弯曲β折叠片层结构的一部分。该结构模型中的两个天冬氨酸残基具有高度的溶剂可及性,能够被胞质因子识别。LOX-1清道夫受体中DDL基序的丙氨酸三联体替代显著降低了OxLDL的内吞作用。将LOX-1胞质结构域移植到转铁蛋白受体报告分子中,赋予了这种杂合蛋白高效的内吞作用。杂合的LOX-1-转铁蛋白受体(TfR)蛋白中DDL基序的突变也显著降低了受体介导的内吞作用。因此,LOX-胞质结构域内一个可移植的内吞基序是确保促动脉粥样硬化的OxLDL颗粒有效内化所必需的。